A carregar...
Brentuximab vedotin followed by bendamustine supercharge for refractory or relapsed Hodgkin lymphoma
We evaluated the impact on progression-free survival (PFS) of achieving a deep metabolic response at 2-deoxy-2[(18)F] fluoro-d-glucose positron emission tomography (FDG-PET) in patients with refractory or relapsed (R/R) classic Hodgkin lymphoma (cHL) following a new salvage regimen named Bv+Bs (bren...
Na minha lista:
| Publicado no: | Blood Adv |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Hematology
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6517654/ https://ncbi.nlm.nih.gov/pubmed/31088808 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000123 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|